COM:VENUSMEDTECH
杭州启明医疗器械股份有限公司
- Stock
Last Close
5.62
23/07 20:00
Market Cap
2.46B
Beta: -
Volume Today
6.42M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 13.05M - | 20.74M 58.89% | 42.35M 104.21% | 75.21M 77.61% | 97.46M 29.58% | 108.67M 11.50% | ||
average payables | 1.96M - | 1.22M 37.93% | 3.37M 177.08% | 7.02M 108.18% | 8.94M 27.27% | 21.49M 140.43% | ||
average receivables | 297.00M - | |||||||
book value per share | 0.18 - | 1.18 538.48% | 9.76 730.70% | 9.32 4.52% | 10.36 11.18% | 8.24 20.51% | 6.63 19.52% | |
capex per share | -0.05 - | -0.07 36.30% | -0.08 16.72% | -0.30 284.34% | -0.33 9.20% | -0.41 23.34% | ||
capex to depreciation | -3.08 - | -2.64 14.32% | -0.85 67.88% | -3.29 287.63% | -2.81 14.51% | -1.59 43.42% | ||
capex to operating cash flow | 0.24 - | 0.18 25.97% | 0.08 53.83% | 0.52 547.16% | 0.32 39.30% | 0.25 22.86% | ||
capex to revenue | -1.07 - | -0.23 78.54% | -0.11 54.29% | -0.45 327.35% | -0.35 22.32% | -0.44 26.00% | ||
cash per share | 0.18 - | 0.42 128.78% | 7.76 1,747.49% | 6.72 13.32% | 6.73 0.05% | 4.29 36.21% | 1.78 58.41% | |
days of inventory on hand | 1.12K - | 372.07 66.70% | 234.36 37.01% | 448.36 91.31% | 361.02 19.48% | 412.11 14.15% | 403.49 2.09% | |
days payables outstanding | 348.75 - | 21.92 93.71% | 13.73 37.38% | 39.63 188.70% | 34.90 11.93% | 36.03 3.22% | 120.95 235.73% | |
days sales outstanding | 215.87 - | |||||||
debt to assets | 0.19 - | 0.10 47.34% | 0.04 59.29% | 0.01 80.97% | 0.01 82.57% | 0.17 1,129.41% | 0.18 5.31% | |
debt to equity | 0.50 - | 0.22 56.03% | 0.05 78.05% | 0.01 82.18% | 0.02 81.32% | 0.25 1,501.53% | 0.27 8.90% | |
dividend yield | 0.00 - | |||||||
earnings yield | -0.01 - | -0.02 82.63% | -0.04 79.34% | -0.01 81.63% | -0.04 421.49% | -0.20 474.76% | -0.32 60.46% | |
enterprise value | 13.98B - | 14.66B 4.81% | 8.14B 44.49% | 24.53B 201.49% | 7.71B 68.57% | 4.59B 40.48% | 2.24B 51.11% | |
enterprise value over ebitda | -93.67 - | -51.49 45.04% | -23.83 53.72% | -122.94 415.92% | -13.53 88.99% | -4.70 65.29% | -4.36 7.08% | |
ev to operating cash flow | -169.99 - | -96.77 43.08% | -26.83 72.28% | -103.50 285.81% | -16.88 83.70% | -6.29 62.72% | ||
ev to sales | 769.92 - | 127.07 83.50% | 34.88 72.55% | 88.86 154.77% | 18.54 79.13% | 11.29 39.10% | 4.57 59.56% | |
free cash flow per share | -0.26 - | -0.45 74.97% | -1.05 132.52% | -0.88 16.30% | -1.37 55.61% | -2.07 51.08% | ||
free cash flow yield | -0.01 - | -0.01 66.50% | -0.03 160.59% | -0.01 57.88% | -0.06 328.19% | -0.16 186.98% | ||
graham net net | -0.09 - | -1.00 984.79% | 5.80 682.42% | 5.67 2.14% | 5.74 1.26% | 0.64 88.86% | -1.00 256.48% | |
graham number | 1.28 - | 4.50 250.06% | 16.40 264.59% | 9.68 40.97% | 14.05 45.16% | 21.79 55.09% | 15.67 28.09% | |
income quality | 0.52 - | 0.51 3.25% | 0.79 57.24% | 1.28 60.43% | 1.21 5.10% | 0.63 47.87% | ||
intangibles to total assets | 0.12 - | 0.64 424.11% | 0.18 71.53% | 0.17 6.64% | 0.16 5.08% | 0.35 116.64% | 0.36 2.27% | |
interest coverage | -103.05 - | -91.42 11.29% | -41.09 55.05% | -109.89 167.45% | -326.26 196.91% | -24.42 92.51% | ||
interest debt per share | 0.10 - | 0.27 178.05% | 0.50 87.58% | 0.09 82.91% | 0.17 94.21% | 2.16 1,201.23% | 1.80 16.50% | |
inventory turnover | 0.33 - | 0.98 200.26% | 1.56 58.76% | 0.81 47.73% | 1.01 24.19% | 0.89 12.40% | 0.90 2.14% | |
invested capital | 0.50 - | 0.22 56.03% | 0.05 78.05% | 0.01 82.18% | 0.02 81.32% | 0.25 1,501.53% | 0.27 8.90% | |
market cap | 14.01B - | 14.72B 5.09% | 10.40B 29.33% | 27.21B 161.51% | 10.60B 61.06% | 5.57B 47.44% | 2.23B 59.96% | |
net current asset value | 8.87M - | -273.37M 3,181.60% | 2.28B 934.55% | 2.90B 27.08% | 2.96B 2.16% | 817.45M 72.40% | 96.58M 88.19% | |
net debt to ebitda | 0.15 - | 0.22 45.47% | 6.64 2,871.75% | 13.41 101.96% | 5.06 62.25% | 1.00 80.19% | -0.03 102.73% | |
net income per share | -0.40 - | -0.77 91.92% | -1.22 60.02% | -0.45 63.50% | -0.85 89.52% | -2.56 202.59% | -1.65 35.75% | |
operating cash flow per share | -0.21 - | -0.39 84.12% | -0.98 152.80% | -0.58 40.61% | -1.04 79.90% | -1.67 59.90% | ||
payables turnover | 1.05 - | 16.65 1,490.97% | 26.59 59.68% | 9.21 65.36% | 10.46 13.55% | 10.13 3.12% | 3.02 70.21% | |
receivables turnover | 1.69 - | |||||||
research and ddevelopement to revenue | 6.46 - | 0.91 85.94% | 0.86 5.36% | 0.61 29.52% | 0.62 2.53% | 1.30 108.89% | 1.07 17.68% | |
return on tangible assets | -0.92 - | -0.81 12.01% | -0.13 84.31% | -0.05 59.79% | -0.09 69.87% | -0.33 277.04% | -0.26 21.84% | |
revenue per share | 0.05 - | 0.29 535.04% | 0.75 155.32% | 0.67 10.07% | 0.95 40.58% | 0.93 2.11% | 1.12 20.89% | |
roe | -2.17 - | -0.65 69.94% | -0.13 80.74% | -0.05 61.77% | -0.08 70.47% | -0.31 280.64% | -0.25 20.17% | |
roic | -1.36 - | -0.51 62.90% | -0.12 77.24% | -0.06 47.76% | -0.13 117.07% | -0.23 75.62% | -0.16 29.10% | |
sales general and administrative to revenue | 0.62 - | 0.28 54.25% | 0.85 199.34% | 0.38 55.50% | 0.31 17.98% | 0.47 52.91% | 0.33 30.89% | |
shareholders equity per share | 0.18 - | 1.18 538.48% | 9.76 730.70% | 9.32 4.52% | 10.36 11.18% | 8.24 20.51% | 6.63 19.52% | |
stock based compensation to revenue | 4.05 - | 2.04 49.51% | 0.52 74.68% | 0.03 93.70% | ||||
tangible asset value | 57.47M - | -192.60M 435.12% | 2.38B 1,333.74% | 3.12B 31.36% | 3.81B 21.92% | 1.78B 53.21% | 1.33B 25.48% | |
tangible book value per share | 0.15 - | -0.49 435.12% | 7.64 1,657.61% | 7.63 0.17% | 8.68 13.77% | 4.07 53.14% | 3.03 25.48% | |
working capital | 25.72M - | -205.49M 899.05% | 2.34B 1,236.78% | 2.95B 26.50% | 3.23B 9.35% | 1.98B 38.82% | 785.78M 60.25% |
All numbers in HKD (except ratios and percentages)